Cargando…
A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy
The composition of periprostatic adipose tissue (PPAT) has been shown to play a role in prostate cancer (PCa) progression. We recently reported an inverse association between PCa aggressiveness and elevated PPAT linoleic acid (LA) and eicosapentaenoic acid (EPA) content. In the present study, we ide...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896176/ https://www.ncbi.nlm.nih.gov/pubmed/31752242 http://dx.doi.org/10.3390/cancers11111814 |
_version_ | 1783476724498956288 |
---|---|
author | Figiel, Sandy Bery, Fanny Chantôme, Aurélie Fontaine, Delphine Pasqualin, Côme Maupoil, Véronique Domingo, Isabelle Guibon, Roseline Bruyère, Franck Potier-Cartereau, Marie Vandier, Christophe Fromont, Gaëlle Mahéo, Karine |
author_facet | Figiel, Sandy Bery, Fanny Chantôme, Aurélie Fontaine, Delphine Pasqualin, Côme Maupoil, Véronique Domingo, Isabelle Guibon, Roseline Bruyère, Franck Potier-Cartereau, Marie Vandier, Christophe Fromont, Gaëlle Mahéo, Karine |
author_sort | Figiel, Sandy |
collection | PubMed |
description | The composition of periprostatic adipose tissue (PPAT) has been shown to play a role in prostate cancer (PCa) progression. We recently reported an inverse association between PCa aggressiveness and elevated PPAT linoleic acid (LA) and eicosapentaenoic acid (EPA) content. In the present study, we identified a new signaling pathway with a positive feedback loop between the epithelial-to-mesenchymal transition (EMT) transcription factor Zeb1 and the Ca(2+)-activated K(+) channel SK3, which leads to an amplification of Ca(2+) entry and cellular migration. Using in vitro experiments and ex vivo cultures of human PCa slices, we demonstrated that LA and EPA exert anticancer effects, by modulating Ca(2+) entry, which was involved in Zeb1 regulation and cancer cellular migration. This functional approach using human prostate tumors highlights the clinical relevance of our observations, and may allow us to consider the possibility of targeting cancer spread by altering the lipid microenvironment. |
format | Online Article Text |
id | pubmed-6896176 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68961762019-12-23 A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy Figiel, Sandy Bery, Fanny Chantôme, Aurélie Fontaine, Delphine Pasqualin, Côme Maupoil, Véronique Domingo, Isabelle Guibon, Roseline Bruyère, Franck Potier-Cartereau, Marie Vandier, Christophe Fromont, Gaëlle Mahéo, Karine Cancers (Basel) Article The composition of periprostatic adipose tissue (PPAT) has been shown to play a role in prostate cancer (PCa) progression. We recently reported an inverse association between PCa aggressiveness and elevated PPAT linoleic acid (LA) and eicosapentaenoic acid (EPA) content. In the present study, we identified a new signaling pathway with a positive feedback loop between the epithelial-to-mesenchymal transition (EMT) transcription factor Zeb1 and the Ca(2+)-activated K(+) channel SK3, which leads to an amplification of Ca(2+) entry and cellular migration. Using in vitro experiments and ex vivo cultures of human PCa slices, we demonstrated that LA and EPA exert anticancer effects, by modulating Ca(2+) entry, which was involved in Zeb1 regulation and cancer cellular migration. This functional approach using human prostate tumors highlights the clinical relevance of our observations, and may allow us to consider the possibility of targeting cancer spread by altering the lipid microenvironment. MDPI 2019-11-18 /pmc/articles/PMC6896176/ /pubmed/31752242 http://dx.doi.org/10.3390/cancers11111814 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Figiel, Sandy Bery, Fanny Chantôme, Aurélie Fontaine, Delphine Pasqualin, Côme Maupoil, Véronique Domingo, Isabelle Guibon, Roseline Bruyère, Franck Potier-Cartereau, Marie Vandier, Christophe Fromont, Gaëlle Mahéo, Karine A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy |
title | A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy |
title_full | A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy |
title_fullStr | A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy |
title_full_unstemmed | A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy |
title_short | A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy |
title_sort | novel calcium-mediated emt pathway controlled by lipids: an opportunity for prostate cancer adjuvant therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896176/ https://www.ncbi.nlm.nih.gov/pubmed/31752242 http://dx.doi.org/10.3390/cancers11111814 |
work_keys_str_mv | AT figielsandy anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT beryfanny anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT chantomeaurelie anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT fontainedelphine anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT pasqualincome anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT maupoilveronique anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT domingoisabelle anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT guibonroseline anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT bruyerefranck anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT potiercartereaumarie anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT vandierchristophe anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT fromontgaelle anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT maheokarine anovelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT figielsandy novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT beryfanny novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT chantomeaurelie novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT fontainedelphine novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT pasqualincome novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT maupoilveronique novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT domingoisabelle novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT guibonroseline novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT bruyerefranck novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT potiercartereaumarie novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT vandierchristophe novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT fromontgaelle novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy AT maheokarine novelcalciummediatedemtpathwaycontrolledbylipidsanopportunityforprostatecanceradjuvanttherapy |